Recombinant Human BCMA Protein (aa 78-184) [His] (VAng-3580Lsx)
Recombinant Human BCMA (TNFRSF17) protein, expressed in E. coli. (Uniprot ID: Q02223)
Datasheet
Specifications
Source
E. coli
Target
BCMA
Type
Tumor Antigens
Applications
SDS-PAGE; WB; ELISA.
Formulation
50 mM NaH2PO4, 500 mM NaCl Buffer with 500 mM Imidazole, 10% Glycerol, pH 8.0.
Purity
> 90% pure by SDS-PAGE.
Storage
Store at -20°C to -80°C.
Antigen Information
Introduction
TNFRSF17 (TNF Receptor Superfamily Member 17) is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation.
Alternative Names
TNFRSF17, CD269, BCM, BCMA
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
